Richland, WA, United States of America

Yongren Benjamin Peng

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Xl Sci-Tech, Inc.. Active years: 2011-2014.

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yongren Benjamin Peng: Innovator in Radiotherapy Technologies

Introduction

Yongren Benjamin Peng is a notable inventor based in Richland, WA (US). He has made significant contributions to the field of radiotherapy through his innovative patents. With a total of 2 patents, his work focuses on the development of particulate materials that enhance cancer treatment.

Latest Patents

Peng's latest patents include "Particulate materials for radiotherapy and diagnostics" and "Particulate materials and compositions for radio therapy." Both patents describe timed-bioresorbable particulates, particularly microspheres or fibers, that serve as vehicles for delivering radioisotopes, such as Y-90 and Pd-103, for localized radiotherapy. These particulates can also function as embolic devices. They may be embedded in polymers or dispersed in injectable gels for the treatment of various cancers. The patents highlight the benefits of bioresorption, the ability to control the ratio of radioisotopes in the particulate, and the advantages of non-conductive implants.

Career Highlights

Yongren Benjamin Peng is currently associated with Xl Sci-Tech, Inc., where he continues to advance his research and development efforts in the field of radiotherapy. His work is instrumental in creating innovative solutions for cancer treatment.

Collaborations

Peng collaborates with Xingye Cherry Lei, contributing to the advancement of technologies in their field.

Conclusion

Yongren Benjamin Peng's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving cancer treatment methodologies. His work continues to pave the way for advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…